Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
GnRH Agonist Supplementation in FET
NCT01943812Phase 4Completed
- Start
- Dec 2013
- Primary completion
- Apr 2019
- Modality
- Peptides, Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of triptorelin in infertility (2 arms). Primary endpoint: Pregnancy loss rate at 12 weeks. Started Dec 2013; status: completed.
02
Drugs
triptorelin
03
Conditions
infertility
Beyond the preview
Go deeper on NCT01943812.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01943812.